tiprankstipranks
Genetic Technologies Ltd (GENE)
NASDAQ:GENE
Holding GENE?
Track your performance easily

Genetic Technologies (GENE) Stock Price & Analysis

476 Followers

GENE Stock Chart & Stats


Financials

Annual

Ownership Overview

0.01%<0.01%99.99%
Insiders
<0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.
---

GENE FAQ

What was Genetic Technologies Ltd’s price range in the past 12 months?
Genetic Technologies Ltd lowest stock price was $0.67 and its highest was $3.56 in the past 12 months.
    What is Genetic Technologies Ltd’s market cap?
    Currently, no data Available
    When is Genetic Technologies Ltd’s upcoming earnings report date?
    Genetic Technologies Ltd’s upcoming earnings report date is Feb 26, 2025 which is in 63 days.
      How were Genetic Technologies Ltd’s earnings last quarter?
      Genetic Technologies Ltd released its earnings results on Aug 29, 2024. The company reported -$0.836 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.836.
        Is Genetic Technologies Ltd overvalued?
        According to Wall Street analysts Genetic Technologies Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Genetic Technologies Ltd pay dividends?
          Genetic Technologies Ltd does not currently pay dividends.
          What is Genetic Technologies Ltd’s EPS estimate?
          Genetic Technologies Ltd’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Genetic Technologies Ltd have?
          Genetic Technologies Ltd has 4,847,241 shares outstanding.
            What happened to Genetic Technologies Ltd’s price movement after its last earnings report?
            Genetic Technologies Ltd reported an EPS of -$0.836 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of Genetic Technologies Ltd?
              Currently, no hedge funds are holding shares in GENE
              ---

              Company Description

              Genetic Technologies Ltd

              Genetic Technologies Ltd. engages in the provision of molecular risk assessment for cancer. It operates through the USA and Australia geographical segments. Its product, BREVAGenplus, is a clinically validated risk assessment test for non-hereditary breast cancer. The company was founded on January 5, 1987 and is headquartered in Fitzroy, Australia.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              ADMA Biologics
              VolitionRX
              BioNano Genomics
              Castle Biosciences
              Popular Stocks
              ---
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis